Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
Richard K. Sterling, Eduardo Lissen, Nathan Clumeck et al. · Hepatology · 2006
Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy. However, many models include tests not readily available, and there are limited data from patients with HIV/hepatitis C virus (HCV) coinfection. We aimed to develop a model using routine tests to predict liver fibrosis in patients with HIV/HCV coinfection. A retrospective analysis of liver histology was performed in 832 patients. Liver fibrosis was assessed via Ishak score; patients were categorized as 0-1, 2-3, or 4-6 and were randomly assigned to training (n = 555) or validation (n = 277) sets. Multivariate logistic regression analysis revealed that platelet count (PLT), age, AST, and INR were significantly associated with fibrosis. Additional analysis revealed PLT, age, AST, and ALT as an alternative model. Based on this, a simple index (FIB-4) was developed: age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). The AUROC of the index was 0.765 for differentiation between Ishak stage 0-3 and 4-6. At a cutoff of <1.45 in the validation set, the negative predictive value to exclude advanced fibrosis (stage 4-6) was 90% with a sensitivity of 70%. A cutoff of >3.25 had a positive predictive value of 65% and a specificity of 97%. Using these cutoffs, 87% of the 198 patients with FIB-4 values outside 1.45-3.25 would be correctly classified, and liver biopsy could be avoided in 71% of the validation group. In conclusion, noninvasive tests can accurately predict hepatic fibrosis and may reduce the need for liver biopsy in the majority of HIV/HCV-coinfected patients.
Cited by 4,981 works. doi:10.1002/hep.21178 Open-access PDF
Authors
- Richard K. Sterling
- Eduardo Lissen
- Nathan Clumeck
- Ricard L. Sola
- Mendes Cassia Correa
- Julio S. G. Montaner
- Mark Sulkowski
- Francesca J. Torriani
- Doug Dieterich
- David L. Thomas
- Diethelm Messinger
- Mark Richard Nelson
References
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
- Histological grading and staging of chronic hepatitis
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
- Liver Biopsy
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
- Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
- Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
- Liver biopsy: Complications in 1000 inpatients and outpatients